e-learning
resources
Virtual 2021
05.09.2021
COVID - 19 biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
C. Cilloniz Campos (Barcelona, Spain), H. Peroni (Buenos Aires, Argentina), C. Domingo (Barcelona, Spain), R. Muñoz (Barcelona, Spain), J. Bedini (Barcelona, Spain), A. Soriano (Barcelona, Spain), A. Torres (Barcelona, Spain)
Source:
Virtual Congress 2021 – COVID - 19 biomarkers
Session:
COVID - 19 biomarkers
Session type:
E-poster
Number:
648
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Cilloniz Campos (Barcelona, Spain), H. Peroni (Buenos Aires, Argentina), C. Domingo (Barcelona, Spain), R. Muñoz (Barcelona, Spain), J. Bedini (Barcelona, Spain), A. Soriano (Barcelona, Spain), A. Torres (Barcelona, Spain). The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia. 648
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
SOFA (Sequential Organ Failure Assessment) Score As A Predictor Of Moartality In Ventilated Patients With Multi-drug Resistant Bacteremia
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Association of the Estimated Dead Space Fraction and the Ventilatory Ratio with Mortality in Patients with Acute Respiratory Distress Syndrome
Source: International Congress 2019 – Acute respiratory distress syndrome: developments in diagnostics and outcomes
Year: 2019
The PROGRESS Study - Operationalization of Disease Severity and Prediction ofOutcome using the SOFA Score
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021
Respiratory Symptoms and Lung Function Depend on Smoking Status and Enviromental Conditions
Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors
Year: 2017
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Is there an Optimal Door-to-Treatment Time for Acute Pulmonary Embolism? A National Propensity Match Analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
Analysis of Causes of Diagnostic Difficulties and Features of Clinical Course of Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021
Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
How to Manage Severe Asthma, the Value of Inflammation Monitoring
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
The Analysis Of Pulmonary Risk Factors In Preoperative Evaluation
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Using HealthCare Failure Mode and Effect Analysis™:To Reduce Facial Pressure Injury of Non-invasive Positive Pressure Ventilation Patients.
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019
Impact of Covid-19 Pneumonia on Pulmonary Function, Functional Exercise Capacity and Quality of Life
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP)
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept